| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial
|
Perin, Emerson C.
|
|
2014
|
168 |
1 |
p. 88-95.e2
9413 p.
|
artikel
|
| 2 |
A metabolomic profile is associated with the risk of incident coronary heart disease
|
Vaarhorst, Anika A.M.
|
|
2014
|
168 |
1 |
p. 45-52.e7
5.19999956E8 p.
|
artikel
|
| 3 |
A systematic review of statin-induced muscle problems in clinical trials
|
Ganga, Harsha V.
|
|
2014
|
168 |
1 |
p. 6-15
10 p.
|
artikel
|
| 4 |
Contents
|
|
|
2014
|
168 |
1 |
p. A1-A3
nvt p.
|
artikel
|
| 5 |
CYP2C19 genotype–guided antiplatelet therapy in ST-segment elevation myocardial infarction patients—Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study
|
Bergmeijer, Thomas O.
|
|
2014
|
168 |
1 |
p. 16-22.e1
205 p.
|
artikel
|
| 6 |
Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable?
|
Wimmer, Neil J.
|
|
2014
|
168 |
1 |
p. 103-109
7 p.
|
artikel
|
| 7 |
Dexamethasone for the prevention of postpericardiotomy syndrome: A DExamethasone for Cardiac Surgery substudy
|
Bunge, Jeroen J.H.
|
|
2014
|
168 |
1 |
p. 126-131.e1
1185 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2014
|
168 |
1 |
p. A4-
1 p.
|
artikel
|
| 9 |
EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy
|
Lamas, Gervasio A.
|
|
2014
|
168 |
1 |
p. 37-44.e5
4.399964E6 p.
|
artikel
|
| 10 |
Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
|
Kotsia, Anna
|
|
2014
|
168 |
1 |
p. 68-75.e2
7433 p.
|
artikel
|
| 11 |
Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial
|
Cornel, Jan H.
|
|
2014
|
168 |
1 |
p. 76-87.e1
795 p.
|
artikel
|
| 12 |
Improving outcomes in primary percutaneous coronary intervention: Transradial is worth the time
|
Pancholy, Samir B.
|
|
2014
|
168 |
1 |
p. 1-3
3 p.
|
artikel
|
| 13 |
Information for Readers
|
|
|
2014
|
168 |
1 |
p. A5-
1 p.
|
artikel
|
| 14 |
Letter to the editor concerning the rationale and design of the X-VERT trial by Ezekowitz et al
|
Załęska-Kocięcka, Marta
|
|
2014
|
168 |
1 |
p. e1-
1 p.
|
artikel
|
| 15 |
Nocturnal patterns of heart rate and the risk of mortality after acute myocardial infarction
|
Carney, Robert M.
|
|
2014
|
168 |
1 |
p. 117-125
9 p.
|
artikel
|
| 16 |
Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study
|
Åkerblom, Axel
|
|
2014
|
168 |
1 |
p. 96-102.e2
10105 p.
|
artikel
|
| 17 |
Preprocedural statin use in patients undergoing percutaneous coronary intervention
|
Kenaan, Mohamad
|
|
2014
|
168 |
1 |
p. 110-116.e3
115891 p.
|
artikel
|
| 18 |
Prognosis of elderly ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
|
Ariza-Solé, Albert
|
|
2014
|
168 |
1 |
p. e3-
1 p.
|
artikel
|
| 19 |
Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes
|
Stienen, Susan
|
|
2014
|
168 |
1 |
p. 30-36
7 p.
|
artikel
|
| 20 |
Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial
|
Holman, Rury R.
|
|
2014
|
168 |
1 |
p. 23-29.e2
2878 p.
|
artikel
|
| 21 |
Response to the letter to the editor by Ariza-Solé et al
|
Velders, Matthijs A.
|
|
2014
|
168 |
1 |
p. e5-
1 p.
|
artikel
|
| 22 |
Trends in the pharmacologic management of atrial fibrillation: Data from the Veterans Affairs health system
|
Vaughan-Sarrazin, Mary S.
|
|
2014
|
168 |
1 |
p. 53-59.e1
538 p.
|
artikel
|
| 23 |
Trial to Assess Chelation Therapy (TACT) and equipoise: When evidence conflicts with beliefs
|
Maron, David J.
|
|
2014
|
168 |
1 |
p. 4-5
2 p.
|
artikel
|
| 24 |
Which risk score best predicts perioperative outcomes in nonvalvular atrial fibrillation patients undergoing noncardiac surgery?
|
van Diepen, Sean
|
|
2014
|
168 |
1 |
p. 60-67.e5
6.699941E6 p.
|
artikel
|
Tijdschrift beschrijving